Effectiveness of Casirivimab-Imdevimab and Sotrovimab Monoclonal Antibody Treatment among High-Risk Patients with Sars-Cov-2 Infection: A Real-World Experience. acbr. 2023;7(3):325-336. Accessed September 17, 2026. https://fortunejournals.org/ojs/index.php/acbr/article/view/15015